Search Results - "Hematologic Neoplasms therapy"

GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party

Authors: Olaf Penack Mouad Abouqateb Christophe Peczynski et al.

Contributors: Olaf Penack Mouad Abouqateb Christophe Peczynski et al.

Source: Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
Penack, O, Abouqateb, M, Peczynski, C, Boreland, W, Benakli, M, Kröger, N, Blau, I W, Blaise, D, Sanz, J, Eder, M, Ozdogu, H, Schneidawind, D, Broers, A E C, Wulf, G G, Mussetti, A, Moiseev, I, Graham, C, Schoemans, H & Peric, Z 2025, ' GVHD prophylaxis in matched related stem cell transplantation : Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party ', Leukemia, vol. 39, no. 6, 102944, pp. 1503-1511 . https://doi.org/10.1038/s41375-025-02619-1

Subject Terms: Male, Adult, BLOOD, Transplantation Conditioning, Antilymphocyte Serum/therapeutic use, Immunology, Graft vs Host Disease, Article, Young Adult, SDG 3 - Good Health and Well-being, 3211 Oncology and carcinogenesis, VERSUS-HOST-DISEASE, Humans, Transplantation, Homologous, 1112 Oncology and Carcinogenesis, Hematopoietic Stem Cell Transplantation/adverse effects, Cyclophosphamide, Antilymphocyte Serum, Aged, Transplantation Conditioning/methods, Science & Technology, Hematologic Neoplasms/therapy, CHRONIC GRAFT, Hematopoietic Stem Cell Transplantation, 3202 Clinical sciences, 1103 Clinical Sciences, Hematology, Middle Aged, PREVENTION, Survival Rate, Oncology, Cyclophosphamide/therapeutic use, Hematologic Neoplasms, Immunosuppressive Agents/therapeutic use, TRIAL, Female, Graft vs Host Disease/prevention & control, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine, LEUKEMIA, Immunosuppressive Agents, Follow-Up Studies

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/40247107
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=22637
https://resolver.sub.uni-goettingen.de/purl?gro-2/148932
https://kclpure.kcl.ac.uk/portal/en/publications/4038e14f-1106-449e-a601-9ec36566c09e

Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies

Authors: Matthew J. Frigault Charlotte E. Graham Trisha R. Berger et al.

Source: Blood. 144:1153-1167

Subject Terms: Male, Adult, 0301 basic medicine, Tetraspanins, T-Lymphocytes, Antigens, CD7, CD7/metabolism, Immunotherapy, Adoptive, 03 medical and health sciences, Antigens, CD, Antigens, Neoplasm, Recurrence, Receptors, Humans, Antigens, Aged, 0303 health sciences, Receptors, Chimeric Antigen, Hematologic Neoplasms/therapy, Neoplasm/immunology, Hematopoietic Stem Cell Transplantation, T-Lymphocytes/immunology, Middle Aged, CD, 3. Good health, Hematologic Neoplasms, Adoptive/methods, Female, Immunotherapy, Chimeric Antigen/immunology

Access URL: https://pubmed.ncbi.nlm.nih.gov/38781564

Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities

Authors: Torsten Schroeder Tjark Martens Lars Fransecky et al.

Source: Intensive Care Med

Subject Terms: Receptors, Chimeric Antigen, Cytokine Release Syndrome/immunology [MeSH], Immunotherapy, Adoptive/adverse effects [MeSH], Neurotoxicity Syndromes/etiology [MeSH], Humans [MeSH], Receptors, Chimeric Antigen/immunology [MeSH], Cytokine Release Syndrome/therapy [MeSH], ICAHT, Intensive Care, Receptors, Chimeric Antigen/therapeutic use [MeSH], Narrative Review, Cytokine Release Syndrome/etiology [MeSH], CAR-T, Hematologic Neoplasms/therapy [MeSH], CAR-T complications, ICANS, Hematologic Neoplasms/immunology [MeSH], Immunotherapy, Adoptive/methods [MeSH], CRS, Hematologic Neoplasms, Humans, Neurotoxicity Syndromes, Cytokine Release Syndrome, Immunotherapy, Adoptive

Access URL: https://pubmed.ncbi.nlm.nih.gov/39172238
https://repository.publisso.de/resource/frl:6502880

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

Authors: Anne Mea Spanjaart Per Ljungman Gloria Tridello et al.

Contributors: Anne Mea Spanjaart Per Ljungman Gloria Tridello et al.

Source: Leukemia
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)

Subject Terms: Male, Cancer Research, [SDV]Life Sciences [q-bio], COVID-19 (Malaltia) - Mortalitat, Immunotherapy, Adoptive, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva, Child, Receptors, Chimeric Antigen, COVID-19, COVID-19/immunology [MeSH], Aged [MeSH], Receptors, Chimeric Antigen/immunology [MeSH], COVID-19/therapy [MeSH], COVID-19/mortality [MeSH], Male [MeSH], SARS-CoV-2/immunology [MeSH], Child [MeSH], Hematologic Neoplasms/mortality [MeSH], Adolescent [MeSH], Female [MeSH], Immunotherapy, Adoptive/adverse effects [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Middle Aged [MeSH], Europe/epidemiology [MeSH], Survival Rate [MeSH], Article, Hematologic Neoplasms/therapy [MeSH], Young Adult [MeSH], 631/250/251, 631/67/1990, Hematologic Neoplasms/immunology [MeSH], Immunotherapy, Adoptive/methods [MeSH], article, Child, Preschool [MeSH], Sang - Malalties - Immunoteràpia, Hematology, Middle Aged, 3. Good health, [SDV] Life Sciences [q-bio], Europe, Survival Rate, Otros calificadores::Otros calificadores::/terapia, Treatment Outcome, Oncology, Hematologic Neoplasms, Child, Preschool, VACCINATION, Female, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine, Adult, Adolescent, Immunology, Other subheadings::Other subheadings::/therapy, SARS-COV-2, Young Adult, SDG 3 - Good Health and Well-being, 3211 Oncology and carcinogenesis, DISEASES::Neoplasms::Neoplasms by Site::Hematologic Neoplasms, Humans, 1112 Oncology and Carcinogenesis, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, Aged, Other subheadings::Other subheadings::Other subheadings::Other subheadings::/mortality, Science & Technology, SARS-CoV-2, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, 3202 Clinical sciences, 1103 Clinical Sciences, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento, Otros calificadores::Otros calificadores::Otros calificadores::Otros calificadores::/mortalidad, Avaluació de resultats (Assistència sanitària), ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias hematológicas

File Description: application/pdf; pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39043963
https://hdl.handle.net/11351/12651
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15097
https://dspace.library.uu.nl/handle/1874/455493
https://pure.amsterdamumc.nl/en/publications/b1e47daf-4a42-4db4-a824-b8b34f6c134e
https://doi.org/10.1038/s41375-024-02336-1
https://lirias.kuleuven.be/handle/20.500.12942/752756
https://doi.org/10.1038/s41375-024-02336-1
https://hal.science/hal-04921717v1
https://doi.org/10.1038/s41375-024-02336-1
https://repository.publisso.de/resource/frl:6519899

How risky is a second allogeneic stem cell transplantation?

Authors: Penack, Olaf Abouqateb, Mouad Peczynski, Christophe et al.

Source: Leukemia

Subject Terms: Male, Adult, Adolescent, Immunology, Medizin, Graft vs Host Disease, Hematologic Neoplasms/mortality [MeSH], Adolescent [MeSH], Female [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Risk Factors [MeSH], Hematopoietic Stem Cell Transplantation/adverse effects [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], 692/699/1541/1990/283, Recurrence [MeSH], Survival Rate [MeSH], Article, Male [MeSH], 692/308/575, Hematologic Neoplasms/therapy [MeSH], Young Adult [MeSH], Graft vs Host Disease/etiology [MeSH], Hematopoietic Stem Cell Transplantation/methods [MeSH], Transplantation, Homologous [MeSH], article, RELAPSE, RETROSPECTIVE ANALYSIS, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Recurrence, 3211 Oncology and carcinogenesis, UNRELATED DONORS, Humans, Transplantation, Homologous, 1112 Oncology and Carcinogenesis, ACUTE-LEUKEMIA, Aged, OUTCOMES, Science & Technology, 3202 Clinical sciences, Hematopoietic Stem Cell Transplantation, 1103 Clinical Sciences, Hematology, Middle Aged, 3. Good health, Survival Rate, Oncology, Hematologic Neoplasms, Female, Neoplasm Recurrence, Local, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine

File Description: application/pdf; pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38918561
https://hdl.handle.net/20.500.11768/175914
https://doi.org/10.1038/s41375-024-02318-3
https://lirias.kuleuven.be/handle/20.500.12942/745706
https://doi.org/10.1038/s41375-024-02318-3
https://repository.publisso.de/resource/frl:6524100
https://www.ncbi.nlm.nih.gov/pubmed/38918561
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85196827847
https://doi.org/10.1038/s41375-024-02318-3

Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT

Authors: Pagliuca, Simona Schmid, Christoph Santoro, Nicole et al.

Source: The Lancet Haematology. 11:e448-e458

Subject Terms: Lymphocyte Transfusion / methods, Hematologic Neoplasms / therapy, Hematopoietic Stem Cell Transplantation / adverse effects, Hematopoietic Stem Cell Transplantation, Tissue Donors, 3. Good health, Hematopoietic Stem Cell Transplantation / methods, Hematologic Neoplasms, Humans, Lymphocyte Transfusion, Practice Guidelines as Topic, Transplantation, Homologous EMTREE drug terms alpha interferon, blinatumomab, brentuximab vedotin, CD20 antigen, cytarabine, decitabine, gilteritinib, midostaurin, protein tyrosine kinase inhibitor, ruxolitinib, sorafenib, venetoclax EMTREE medical terms acute graft versus host disease, acute myeloid leukemia, allogeneic hematopoietic stem cell transplantation, B cell acute lymphoblastic leukemia, chronic lymphatic leukemia, chronic myeloid leukemia, diffuse large B cell lymphoma, donor lymphocyte infusion, flow cytometry, follicular lymphoma, hematologic malignancy, hematopoietic stem cell transplantation, Hodgkin disease, human, immune response, immunogenicity, liver function test, mantle cell lymphoma, multiple myeloma, myelodysplastic syndrome, myeloproliferative neoplasm, natural killer cell, non-Hodgkin lymphoma, questionnaire, Review, risk factor, systematic review, T cell acute lymphoblastic leukemia, adverse event, allotransplantation, donor, hematologic disease, lymphocyte transfusion, practice guideline, procedures, therapy, Transplantation, Homologous

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38796194
https://hdl.handle.net/11588/993407
https://www-sciencedirect-com.udaezproxy.idm.oclc.org/science/article/abs/pii/S235230262400098X?via=ihub
https://doi.org/10.1016/s2352-3026(24)00098-x
https://hdl.handle.net/11564/863494
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/113380
https://doi.org/10.1016/s2352-3026(24)00098-x

Selective haematological cancer eradication with preserved haematopoiesis

Authors: Garaudé, Simon Marone, Romina Lepore, Rosalba et al.

Source: Nature

Subject Terms: Male, 0301 basic medicine, Immunoconjugates, Hematologic Neoplasms / drug therapy, Article, Mice, 03 medical and health sciences, Antibody Specificity, Cell Line, Tumor, Immunoconjugates / pharmacology, Leukocyte Common Antigens / metabolism, Animals, Humans, Hematopoiesis / drug effects, Hematopoietic Stem Cells / metabolism, Hematopoietic Stem Cells / cytology, 0303 health sciences, Hematologic Neoplasms / therapy, Hematopoietic Stem Cells / drug effects, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells, Immunoconjugates / therapeutic use, Hematopoiesis, 3. Good health, Hematologic Neoplasms, Leukocyte Common Antigens, Female, Hematologic Neoplasms / immunology, Leukocyte Common Antigens / immunology

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38778101
https://archive-ouverte.unige.ch/unige:179136
https://doi.org/10.1038/s41586-024-07456-3

Palliative care for patients with hematologic malignancies in Germany: a nationwide survey on everyday practice and influencing factors from the perspective of treating physicians

Authors: Cordula Gebel Isabel Kruschel Steffi Bodinger et al.

Source: Ann Hematol

Subject Terms: Terminal Care, 03 medical and health sciences, 0302 clinical medicine, Research, Hematologic Neoplasms, Germany, Physicians, Palliative Care, Humans, Physicians [MeSH], Terminal Care [MeSH], Humans [MeSH], Integration, Hematologic malignancies, Palliative Care [MeSH], Germany/epidemiology [MeSH], Palliative care, Referral, Hematologic Neoplasms/therapy [MeSH], Hematologic Neoplasms/epidemiology [MeSH], Survey

Access URL: https://pubmed.ncbi.nlm.nih.gov/38538976
https://repository.publisso.de/resource/frl:6519071

ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?

Authors: Olaf Penack Mouad Abouqateb Christophe Peczynski et al.

Contributors: Olaf Penack Mouad Abouqateb Christophe Peczynski et al.

Source: Leukemia

Subject Terms: Male, Adult, BLOOD, Transplantation Conditioning, Adolescent, Immunology, Medizin, Graft vs Host Disease, PROPHYLAXIS, Article, Young Adult, 03 medical and health sciences, 0302 clinical medicine, 3211 Oncology and carcinogenesis, VERSUS-HOST-DISEASE, Humans, Transplantation, Homologous, 1112 Oncology and Carcinogenesis, Cyclophosphamide, Antilymphocyte Serum, Aged, Retrospective Studies, Science & Technology, CHRONIC GRAFT, 3202 Clinical sciences, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cell, 1103 Clinical Sciences, Hematology, GLOBULIN, Middle Aged, EUROPEAN-SOCIETY, 3. Good health, Survival Rate, Oncology, Hematologic Neoplasms, Transplantation Conditioning/methods [MeSH], Aged [MeSH], Cyclophosphamide/therapeutic use [MeSH], Male [MeSH], 692/308/575, Transplantation, Homologous [MeSH], Graft vs Host Disease/prevention, Hematologic Neoplasms/mortality [MeSH], Adolescent [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Antilymphocyte Serum/therapeutic use [MeSH], Adult [MeSH], Unrelated Donors [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Hematopoietic Stem Cell Transplantation/adverse effects [MeSH], Survival Rate [MeSH], Hematologic Neoplasms/therapy [MeSH], Young Adult [MeSH], Graft vs Host Disease/etiology [MeSH], Hematopoietic Stem Cell Transplantation/methods [MeSH], Immunosuppressive Agents/therapeutic use [MeSH], 692/308/2171, article, TRIAL, Female, Cancers, 3201 Cardiovascular medicine and haematology, Unrelated Donors, Life Sciences & Biomedicine, Immunosuppressive Agents, Stem Cell Transplantation, Follow-Up Studies

File Description: application/pdf; pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38538862
https://lirias.kuleuven.be/handle/20.500.12942/745709
https://doi.org/10.1038/s41375-024-02225-7
http://hdl.handle.net/10138/575259
https://repository.publisso.de/resource/frl:6523474
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85188841913
https://doi.org/10.1038/s41375-024-02225-7

Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System

Authors: Sparano, Francesco Giesinger, Johannes M Gaidano, Gianluca et al.

Contributors: Sparano, Francesco Giesinger, Johannes M Gaidano, Gianluca et al.

Source: JCO Oncology Practice. 20:438-447

Subject Terms: Financial Stress, Settore MEDS-09/B - Malattie del sangue, hematologic malignancie, Sciences de la santé humaine, Hematologic Neoplasms/complications, 03 medical and health sciences, 0302 clinical medicine, Financial Toxicity, Health-Related Quality of Life, Hematologic Malignancies, Surveys and Questionnaires, Humans, Human health sciences, financial toxicity, Hematologic Neoplasms/therapy, Oncology (nursing), Health Policy, EORTC QLQ-C30, Hematology, Settore MED/15, 3. Good health, health-related quality of life, Oncology, Hematologic Neoplasms/epidemiology, Hematologic Neoplasms, Quality of Life, hematologic malignancies, Universal Health Care, Hématologie

File Description: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

Access URL: https://pubmed.ncbi.nlm.nih.gov/38207239
https://hdl.handle.net/2268/315927
https://doi.org/10.1200/OP.23.00434
https://hdl.handle.net/11380/1367902
https://doi.org/10.1200/op.23.00434
https://hdl.handle.net/11585/969795
https://doi.org/10.1200/OP.23.00434
https://ascopubs.org/doi/pdf/10.1200/OP.23.00434
https://hdl.handle.net/2318/1966230
https://doi.org/10.1200/OP.23.00434

Deuxième allogreffe (mise à jour). Recommandations de la Société francophone de greffe de moelle osseuse et de thérapie cellulaire (SFGM-TC)

Authors: Yafour, Nabil Couturier, Marie-Anne Borel, Cécile et al.

Source: Bulletin du Cancer. 111:S29-S39

Subject Terms: Hematopoietic cell transplantation, Hematologic Neoplasms / therapy, Second allogeneic, Hematopoietic Stem Cell Transplantation, Guidelines, Recommendations, SFGM-TC, Greffe de cellules souches hématopoïétiques, 3. Good health, Deuxième allogreffe, Recurrence, Humans, Neoplasm Recurrence, Local, Bone Marrow Transplantation

File Description: application/pdf

Access URL: https://archive-ouverte.unige.ch/unige:179773
https://doi.org/10.1016/j.bulcan.2023.03.005

Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations

Authors: Shumilov, Evgenii Mazzeo, Paolo Ghandili, Susanne et al.

Contributors: Shumilov, Evgenii Mazzeo, Paolo Ghandili, Susanne et al.

Source: Ann Hematol
Shumilov, Evgenii; Mazzeo, Paolo; Ghandili, Susanne; Künstner, Axel; Weidemann, Sören; Banz, Yara; Ströbel, Philipp; Pollak, Matthias; Kolloch, Lina; Beltraminelli, Helmut; Kerkhoff, Andrea; Mikesch, Jan-Henrik; Schliemann, Christoph; Haase, Detlef; Wulf, Gerald; Legros, Myriam; Lenz, Georg; Feldmeyer, Laurence; Pabst, Thomas; Witte, Hanno; ... (2024). Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Annals of hematology, 103(5), pp. 1587-1599. Springer-Verlag 10.1007/s00277-023-05587-7 <http://dx.doi.org/10.1007/s00277-023-05587-7>

Subject Terms: Myeloproliferative Disorders, Skin Neoplasms, 610 Medicine & health, HLA-DR Antigens, Dendritic Cells, Tagraxofusp, Dendritic Cells/pathology [MeSH], Immunohistochemistry, CD123, HLA-DR Antigens [MeSH], Hematologic Neoplasms/genetics [MeSH], Humans [MeSH], Comprehensive diagnostics, Retrospective Studies [MeSH], Original Article, Hematologic Neoplasms/therapy [MeSH], Blastic plasmacytoid dendritic cell neoplasm (BPDCN), Bone Marrow/pathology [MeSH], Hematologic Neoplasms/diagnosis [MeSH], Skin Neoplasms/metabolism [MeSH], Myeloproliferative Disorders/pathology [MeSH], Skin Neoplasms/diagnosis [MeSH], Skin Neoplasms/therapy [MeSH], Flow cytometry, Leukemia, Myeloid, Acute/pathology [MeSH], 3. Good health, Leukemia, Myeloid, Acute, Bone Marrow, Hematologic Neoplasms, 570 Life sciences, biology, Humans, Retrospective Studies

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38194088
https://resolver.sub.uni-goettingen.de/purl?gro-2/140252
https://boris.unibe.ch/191423/
https://repository.publisso.de/resource/frl:6518955

Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Authors: Jürgen Finke Claudia Schmoor Francis Ayuk et al.

Contributors: Jürgen Finke Claudia Schmoor Francis Ayuk et al.

Source: Bone Marrow Transplant

Subject Terms: Adult, Male, ddc:610, Adolescent, T-Lymphocytes, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Graft vs Host Disease/prevention, Hematologic Neoplasms/mortality [MeSH], 692/699/1541/1990/283/1897, Adolescent [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Aged [MeSH], T-Lymphocytes/immunology [MeSH], Adult [MeSH], Unrelated Donors [MeSH], Humans [MeSH], Prospective Studies [MeSH], Middle Aged [MeSH], Graft vs Host Disease/mortality [MeSH], 692/699/1541/1990/283, Article, Male [MeSH], Disease-Free Survival [MeSH], Hematologic Neoplasms/therapy [MeSH], Young Adult [MeSH], 692/308/2779/109/1943, Hematopoietic Stem Cell Transplantation/methods [MeSH], article, Middle Aged, Disease-Free Survival, ddc, 3. Good health, Young Adult, Hematologic Neoplasms, Humans, Female, Prospective Studies, Unrelated Donors, Aged, Follow-Up Studies

File Description: application/pdf; pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38493275
https://resolver.sub.uni-goettingen.de/purl?gro-2/142515
https://opus.bibliothek.uni-augsburg.de/opus4/files/114442/s41409-024-02264-9.pdf
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/114442
https://doi.org/10.1038/s41409-024-02264-9
https://nbn-resolving.org/urn:nbn:de:bvb:384-opus4-1144428
https://repository.publisso.de/resource/frl:6496279
https://mediatum.ub.tum.de/doc/1770259/document.pdf

Blastic plasmacytoid dendritic cell neoplasm: a Swiss case series of a very rare disease and a structured review of the literature.

Authors: Meier-Lienhard, R. Suter, C. Pabst, T. et al.

Source: Swiss medical weekly, vol. 155, pp. 3885

Subject Terms: Humans, Switzerland/epidemiology, Dendritic Cells/pathology, Male, Female, Middle Aged, Aged, Rare Diseases/therapy, Rare Diseases/epidemiology, Adult, Hematologic Neoplasms/therapy, Hematologic Neoplasms/epidemiology, Hematologic Neoplasms/diagnosis, Prognosis, Retrospective Studies, Blastic Plasmacytoid Dendritic Cell Neoplasm, Recombinant Fusion Proteins

File Description: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/39877935; info:eu-repo/semantics/altIdentifier/eissn/1424-3997; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_76A1F03DF4589; https://serval.unil.ch/notice/serval:BIB_76A1F03DF458; https://serval.unil.ch/resource/serval:BIB_76A1F03DF458.P001/REF.pdf

Availability: https://serval.unil.ch/notice/serval:BIB_76A1F03DF458
https://doi.org/10.57187/s.3885
https://serval.unil.ch/resource/serval:BIB_76A1F03DF458.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_76A1F03DF4589

Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis

Authors: Troullioud Lucas, Alexandre G Lindemans, Caroline A Bhoopalan, Senthil Velan et al.

Contributors: Troullioud Lucas, Alexandre G Lindemans, Caroline A Bhoopalan, Senthil Velan et al.

Source: Cytotherapy. 25:977-985

Subject Terms: Cancer Research, Hematopoietic Stem Cell Transplantation/methods, Graft vs Host Disease/etiology, Immunology, GVHD, Graft vs Host Disease, Young Adult, non-relapse mortality, Immune Reconstitution, Research Support, N.I.H., Extramural, Journal Article, Immunology and Allergy, Humans, Transplantation, Homologous, Genetics(clinical), Child, Retrospective Studies, relapse, allogeneic hematopoietic cell transplant, Transplantation, Hematologic Neoplasms/therapy, Hematopoietic Stem Cell Transplantation, Cell Biology, hematologic malignancies, 3. Good health, Leukemia, Myeloid, Acute, Oncology, Hematologic Neoplasms

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/37330731
https://dspace.library.uu.nl/handle/1874/451973

Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)

Authors: Simone Cesaro Malgorzata Mikulska Hans H. Hirsch et al.

Contributors: Simone Cesaro Malgorzata Mikulska Hans H. Hirsch et al.

Source: Leukemia
Leukemia, vol. 37, no. 9, pp. 1933-1938

Subject Terms: Science & Technology, Receptors, Chimeric Antigen, Leukemia, Humans, COVID-19, Leukemia/complications, Leukemia/therapy, Hematologic Neoplasms/complications, Hematologic Neoplasms/therapy, Hematopoietic Stem Cell Transplantation/adverse effects, Immunology, 3202 Clinical sciences, Hematopoietic Stem Cell Transplantation, 1103 Clinical Sciences, Hematology, ECIL 9, 3. Good health, Oncology, 3211 Oncology and carcinogenesis, Hematologic Neoplasms, Correspondence, 1112 Oncology and Carcinogenesis, Infection, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/37460673
https://serval.unil.ch/notice/serval:BIB_68C8171C3E09
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_68C8171C3E098
https://serval.unil.ch/resource/serval:BIB_68C8171C3E09.P001/REF.pdf
https://hdl.handle.net/10807/260266
https://doi.org/10.1038/s41375-023-01938-5

Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)

Authors: Pagano, Livio Maschmeyer, Georg Lamoth, Frederic et al.

Contributors: Pagano, Livio Maschmeyer, Georg Lamoth, Frederic et al.

Source: Leukemia
Leukemia, vol. 39, no. 7, pp. 1547-1557

Subject Terms: Antifungal Agents, Immunology, Review Article, THERAPY, 3211 Oncology and carcinogenesis, Humans, 1112 Oncology and Carcinogenesis, ADULT PATIENTS, AZACITIDINE, INVASIVE FUNGAL-INFECTIONS, ACUTE LYMPHOBLASTIC-LEUKEMIA, Science & Technology, 3202 Clinical sciences, STEM-CELL TRANSPLANTATION, 1103 Clinical Sciences, Hematology, OPEN-LABEL, EFFICACY, MYELOFIBROSIS, [SDV] Life Sciences [q-bio], N/A, Oncology, Mycoses, Hematologic Neoplasms, Practice Guidelines as Topic, RISK-FACTORS, ECIL, 3201 Cardiovascular medicine and haematology, Life Sciences & Biomedicine, Antifungal Agents/therapeutic use, Hematologic Neoplasms/complications, Hematologic Neoplasms/therapy, Mycoses/prevention & control, Mycoses/etiology

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/40200079
https://u-paris.hal.science/hal-05120492v1
https://doi.org/10.1038/s41375-025-02586-7
https://u-paris.hal.science/hal-05120492v1/document
https://lirias.kuleuven.be/handle/20.500.12942/769127
https://doi.org/10.1038/s41375-025-02586-7
https://serval.unil.ch/notice/serval:BIB_9D4A68C5B6B1
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_9D4A68C5B6B19
https://serval.unil.ch/resource/serval:BIB_9D4A68C5B6B1.P001/REF.pdf
https://hdl.handle.net/11585/1026915
https://doi.org/10.1038/s41375-025-02586-7
https://hdl.handle.net/2318/2067682
https://doi.org/10.1038/s41375-025-02586-7

European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

Authors: Nanni, Cristina Kobe, Carsten Baeßler, Bettina et al.

Source: Nanni, C, Kobe, C, Baeßler, B, Baues, C, Boellaard, R, Borchmann, P, Buck, A, Buvat, I, Chapuy, B, Cheson, B D, Chrzan, R, Cottereau, A-S, Dührsen, U, Eikenes, L, Hutchings, M, Jurczak, W, Kraeber-Bodéré, F, Lopci, E, Luminari, S, MacLennan, S, Mikhaeel, N G, Nijland, M, Rodríguez-Otero, P, Treglia, G, Withofs, N, Zamagni, E, Zinzani, P L, Zijlstra, J M, Herrmann, K & Kunikowska, J 2023, 'European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations : molecular imaging and therapy in haematological tumours', The Lancet Haematology, vol. 10, no. 5, pp. e367-e381. https://doi.org/10.1016/S2352-3026(23)00030-3

Subject Terms: Consensus, Hematologic Neoplasms/therapy, PET/CT, FDG, European Association of Nuclear Medicine, EANM, recommendations, molecular imaging, therapy, haematological tumours, Radiologie, médecine & imagerie nucléaire, lymphoma, Hematology, Sciences de la santé humaine, 3. Good health, Molecular Imaging, myeloma, Artificial Intelligence, Hematologic Neoplasms, Hematologic Neoplasms/diagnostic imaging, Humans, Human health sciences, Nuclear Medicine, Radiology, nuclear medicine & imaging

Access URL: https://pubmed.ncbi.nlm.nih.gov/37142345
https://research.vumc.nl/en/publications/9f9c37d7-2df1-4f54-b8f0-47fe951e3f1b
https://hdl.handle.net/2268/307168
https://doi.org/10.1016/S2352-3026(23)00030-3
https://hdl.handle.net/11585/960695
https://doi.org/10.1016/s2352-3026(23)00030-3
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00030-3/abstract

An Overview of Cytokine Release Syndrome and Other Side Effects of CAR-T Cell Therapy

Authors: Genoud, Vassilis Migliorini, Denis

Source: Praxis. 112:189-193

Subject Terms: Récepteur d'antigène chimérique, Cell therapies, Hematologic Neoplasms / therapy, Receptors, Chimeric Antigen, Immune effector cell-associated neurotoxicity syndrome, Cytokine Release Syndrome / etiology, Cell- and Tissue-Based Therapy, Cytokine Release Syndrome / therapy, Immuneffektorzell-assoziiertes Neurotoxizitätssyndrom, Zytokinfreisetzungssyndrom, Syndrome de libération cytokinique, Zelltherapien, Chimärer Antigenrezeptor, Receptors, Chimeric Antigen / therapeutic use, Cytokine release syndrome, Syndrome de neurotoxicité associé aux cellules effectrices du système immunitaire, Thérapies cellulaires, Hematologic Neoplasms, Humans, Chimeric antigen receptor, Cytokine Release Syndrome

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/36855881

Conduite à tenir devant une prédisposition génétique aux hémopathies malignes chez un patient candidat à l’allogreffe de cellules souches hématopoïétiques (CSH) : recommandations de la SFGM-TC

Authors: Coiteux, Valérie Fenwarth, Laurène Duployez, Nicolas et al.

Contributors: Coiteux, Valérie Fenwarth, Laurène Duployez, Nicolas et al.

Source: Bulletin du Cancer. 110:S13-S29

Subject Terms: Leukemia / genetics, Leukemia / therapy, 0301 basic medicine, 0303 health sciences, Hematologic Neoplasms / therapy, Allogeneic hematopoietic, Hémopathies malignes, Prédisposition génétique, stem cell transplantation, Hematologic Diseases, Transplantation Conditioning / methods, [SDV] Life Sciences [q-bio], 03 medical and health sciences, Hematopoietic Stem Cell Transplantation / methods, Hematologic Neoplasms / genetics, Allogeneic hematopoietic stem cell transplantation, Genetic predispositions, Humans, Genetic Predisposition to Disease, Hereditary hematological malignancy, Allogreffe de CSH, Hereditary hematological, malignancy

File Description: application/pdf

Access URL: https://hal.univ-lille.fr/hal-04423937v1/document
https://doi.org/10.1016/j.bulcan.2022.09.002
https://hal.univ-lille.fr/hal-04423937v1